G1 Therapeutics, Inc. announced it raised $50 Million in an amended filing from an offering of $50 Million

Jul 01, 2016•over 9 years ago

Amount Raised

$50 Million

Research Triangle ParkBiotechnology

Company Information

Company

G1 Therapeutics, Inc.

Location

79 T.W. ALEXANDER DRIVE

Research Triangle Park, North Carolina, United States

About

G1 Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of innovative therapies that improve the lives of those affected by cancer.

Related People

9 contacts

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

G1 Therapeutics, Inc. announced it raised $50 Million in an amended filing from an offering of $50 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information